Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

The Latest Correction Makes Square Stock a Good Buy for the Long Haul

By Will Ashworth, InvestorPlace Contributor

In the latest mini-correction of tech stocks, Square has seen its shares lose their momentum. If you own SQ stock, it’s time to buy more.

Novavax’s Run to $200 by the End of 2020 Is Looking Less Likely 

By Will Ashworth, InvestorPlace Contributor

Novavax signed an agreement with the Canadian government for its potential Covid-19 vaccine Aug. 31. NVAX stock has been falling ever since.

Sorrento Therapeutics Is a Scary, Risky Potential Buy

By Will Ashworth, InvestorPlace Contributor

Sorrento Therapeutics has lost 44% since firing its chief financial officer on Aug. 19. Is SRNE stock a buy given its drop in recent days?

Here’s Why IBIO’s Choice of IBIO-201 in the Vaccine Race is a Good Thing

By Will Ashworth, InvestorPlace Contributor

Ibio recently announced IBIO-201 as its coronavirus vaccine candidate. Despite a long road ahead, it’s good news for IBIO stock.   

Hertz Stock Could Survive Bankruptcy. Does Anybody Care?

By Will Ashworth, InvestorPlace Contributor

Could Hertz shareholders face a similar fate to Whiting Petroleum? If so, should you be buying Hertz stock at current prices? 

Load More